SBP solbec pharmaceuticals limited

cure for cancer.........

  1. Tvision
    384 Posts.
    clock Created with Sketch.
    16/10/07
    11:31
    Post #: 2898290
    “We are very pleased to be invited by Dr Nagourney to assist in this patient’s treatment.
    The patient’s tumour type (renal cell carcinoma) fits in with the results we saw in the
    Australian Phase I trials where we saw a patient with end stage RCC respond to the
    Coramsine® therapy. That patient remains in remission to this day.” David Sparling,
    Solbec’s General Manager
    SBP Price at posting: 0.0¢ Sentiment: ST Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.